Further processing options
The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset.
Saved in:
Journal Title: | Journal of Clinical Oncology |
---|---|
Authors and Corporations: | , |
In: | Journal of Clinical Oncology, 29, 2011, 15_suppl, p. e13051-e13051 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Society of Clinical Oncology (ASCO)
|
Subjects: |